{
    "organizations": [],
    "uuid": "2c211b70788d9e91ec0ad55e8bb84c64c2b2804a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-amir-efrati-reports-53-percent-sta/brief-amir-efrati-reports-5-3-percent-stake-in-arcturus-therapeutics-idUSFWN1S71A5",
    "ord_in_thread": 0,
    "title": "BRIEF-Amir Efrati Reports 5.3 Percent Stake In Arcturus Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30 (Reuters) - Arcturus Therapeutics Ltd:\n* AMIR EFRATI - ON APRIL 27, SENT LETTER TO ISRAELI COURT SHOWING OPPOSITION TO TRANSACTION THEY BELIEVE ARCTURUS THERAPEUTICS BOARD HAS BEEN PURSUING\n* AMIR EFRATI REPORTS 5.3 PERCENT STAKE IN ARCTURUS THERAPEUTICS AS OF APRIL 27, 2018 - SEC FILING\n* AMIR EFRATI SAYS INTEND TO REVIEW INVESTMENT IN ARCTURUS THERAPEUTICS ON A CONTINUING BASIS\n* AMIR EFRATI SAYS PURCHASED ARCTURUS THERAPEUTICS' SHARES BASED ON BELIEF THAT SHARES, WHEN PURCHASED, WERE UNDERVALUED Source : bit.ly/2jhVcGg Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-01T05:10:00.000+03:00",
    "crawled": "2018-05-01T00:22:24.018+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "arcturus",
        "therapeutic",
        "ltd",
        "amir",
        "efrati",
        "april",
        "sent",
        "letter",
        "israeli",
        "court",
        "showing",
        "opposition",
        "transaction",
        "believe",
        "arcturus",
        "therapeutic",
        "board",
        "pursuing",
        "amir",
        "efrati",
        "report",
        "percent",
        "stake",
        "arcturus",
        "therapeutic",
        "april",
        "sec",
        "filing",
        "amir",
        "efrati",
        "say",
        "intend",
        "review",
        "investment",
        "arcturus",
        "therapeutic",
        "continuing",
        "basis",
        "amir",
        "efrati",
        "say",
        "purchased",
        "arcturus",
        "therapeutic",
        "share",
        "based",
        "belief",
        "share",
        "purchased",
        "undervalued",
        "source",
        "company",
        "coverage"
    ]
}